Green Thumb Industries (GTBIF) Assets Average (2020 - 2026)
Green Thumb Industries (GTBIF) posted Assets Average of $2.8 billion for Q1 2026, up 3.54% on a QoQ basis from $2.7 billion in Q4 2025, and up 10.1% year-over-year from $2.6 billion in Q1 2025.
Green Thumb Industries (GTBIF) Assets Average (2020 - 2026) Analysis & Trends
Green Thumb Industries' Assets Average history runs 7 years deep, the most recent figure standing at $2.8 billion for Q1 2026.
- Quarterly Assets Average rose 10.1% year-over-year to $2.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 billion (up 10.1% YoY) and the FY2025 annual result came in at $2.7 billion, up 5.97% from the prior year.
- Assets Average was $2.8 billion for Q1 2026 at Green Thumb Industries, up from $2.7 billion in the prior quarter.
- Across five years, Assets Average topped out at $2.8 billion in Q1 2026 and bottomed at $2.4 billion in Q1 2022.
- A 5-year average of $2.5 billion and a median of $2.5 billion in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average surged 64.49% — and 2025, when it grew 0.43%.
- Green Thumb Industries' Assets Average stood at $2.4 billion in 2022, then grew by 2.04% to $2.5 billion in 2023, then increased by 1.25% to $2.5 billion in 2024, then grew by 7.47% to $2.7 billion in 2025, then climbed by 3.54% to $2.8 billion in 2026.
- Business Quant data shows GTBIF's Assets Average at $2.8 billion in Q1 2026, $2.7 billion in Q4 2025, and $2.6 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 2.81 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.81 Bn |
| Dec 31, 2025 | 2.71 Bn |
| Sep 30, 2025 | 2.59 Bn |
| Jun 30, 2025 | 2.56 Bn |
| Mar 31, 2025 | 2.55 Bn |
| Dec 31, 2024 | 2.53 Bn |
| Sep 30, 2024 | 2.53 Bn |
| Jun 30, 2024 | 2.55 Bn |
| Mar 31, 2024 | 2.52 Bn |
| Dec 31, 2023 | 2.49 Bn |
| Sep 30, 2023 | 2.51 Bn |
| Jun 30, 2023 | 2.50 Bn |
| Mar 31, 2023 | 2.46 Bn |
| Dec 31, 2022 | 2.44 Bn |
| Sep 30, 2022 | 2.45 Bn |
| Jun 30, 2022 | 2.42 Bn |
| Mar 31, 2022 | 2.39 Bn |
| Dec 31, 2021 | 2.27 Bn |
| Sep 30, 2021 | 1.97 Bn |
| Jun 30, 2021 | 1.67 Bn |